Elon Musk’s Neuralink has recently achieved a significant milestone with its experimental vision-restoring implant, Blindsight. The U.S. Food and Drug Administration (FDA) has granted the device ...

Neuralink says the Food and Drug Administration has designated its experimental Blindsight implant as a "breakthrough device." The company is developing the technology in an attempt to restore ...

The Tesla CEO said that Neuralink, another one of his tech companies, planned on implanting its new brain chip, Blindsight, into a human patient for the first time in late 2025. Newsweek contacted ...

Billionaire Elon Musk has shared a major Neuralink update at the Qatar Economic Forum with the Neurotechnology company's Brain-Chip Interface Blindsight set for its maiden trial next year.

Neuralink's Blindsight implant aims to restore vision for individuals with complete blindness by bypassing damaged optic nerves and directly interfacing with the brain. Neuralink’s Blindsight ...

Dubbed “Blindsight,” the experimental brain implant gained clearance from the US Food and Drug Administration to participate in the voluntary program. It is one of 58 devices to receive the ...

Neuralink recently announced that it has received "Breakthrough Device Designation" from the FDA for Blindsight, a device designed to restore vision to those who can no longer see. According to ...

Neuralink, a neurotechnology company founded by Mr. Musk, announced in a statement on X that it had “received Breakthrough Device Designation from the FDA” for its Blindsight device. “The Blindsight ...

As Neuralink continues its efforts to develop brain interface technology, one of its irons in the fire is Blindsight, which is a technology and procedure meant to provide eyesight back to those ...

Sept 17 (Reuters) - Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S. Food and Drug Administration's "breakthrough ...